Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.45 |
| ▸ | CDC25B | P30305 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | EEF2K | O00418 | 1/20 | 0.42 |
| ▸ | PLK1 | P53350 | 1/20 | 0.42 |
| ▸ | PLK2 | Q9NYY3 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 3/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 3/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28969836 | 0.97 | CDC25A (0.43) | CDC25ACDC25BPTPN1EEF2KPLK1 | |
| SCHEMBL13986038 | 0.83 | CDC25A (0.38) | CDC25ACDC25BPTPN1EEF2KPLK1 | |
| SCHEMBL17935505 | 0.82 | CDC25A (0.45) | CDC25ACDC25BPTPN1EEF2KPLK1 | |
| SCHEMBL14394520 | 0.79 | CDC25A (0.36) | CDC25ACDC25BPTPN1EEF2KPLK1 | |
| SCHEMBL9841858 | 0.79 | ALDH1A1 (0.41) | CDC25ACDC25BPTPN1EEF2KPLK1 | |
| SCHEMBL16503632 | 0.75 | PTPN1 (0.41) | CDC25ACDC25BPTPN1EEF2KPLK1 | |
| SCHEMBL9454008 | 0.75 | BACE1 (0.64) | CDC25ACDC25BPTPN1IDO1 | |
| SCHEMBL9778297 | 0.74 | ALDH1A1 (0.38) | KDM4EMEN1USP2TP53CYP3A4 | |
| SCHEMBL17969767 | 0.72 | EEF2K (0.45) | CDC25ACDC25BPTPN1EEF2KPLK1 | |
| SCHEMBL6888742 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805398-A | Preparation method of ecteinascidin compound | 江苏恒瑞医药股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-113712917-A | Propofol medium-long chain fat emulsion injection and preparation method thereof | 远大生命科学(武汉)有限公司 | 2021-11-30 | — | — | CN | claimed |
| EP-4419580-B1 | METHOD FOR PROMOTING HYDROSILYLATION REACTION TO PREPARE ESTER-FUNCTIONAL SILOXANE OLIGOMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12398270-B2 | Acrylate-functional branched organosilicon compound, method of preparing same, and copolymer formed therewith | DOW SILICONES CORPORATION (US) | 2025-08-26 | — | — | US | disclosed |
| US-12378264-B2 | Multifunctional organosilicon compound and related methods, compounds, and compositions | DOW SILICONES CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-12371535-B2 | Branched organosilicon compound, method of preparing same, and copolymer formed therewith | DOW SILICONES CORPORATION (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4172165-B1 | PREPARATION OF MULTIFUNCTIONAL ORGANOSILICON COMPOUNDS | DOW SILICONES CORP (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250136763-A1 | SILICONE - VINYLESTER FUNCTIONAL COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN PERSONAL CARE COMPOSITIONS | DOW SILICONES CORP (US) | 2025-05-01 | — | — | US | disclosed |
| US-20250136625-A1 | PROCESS FOR THE PREPARATION OF ORGANIC SILICON COMPOUNDS | BASF SE (DE) | 2025-05-01 | — | — | US | disclosed |
| EP-4508106-A1 | SILICONE - VINYLESTER FUNCTIONAL COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN PERSONAL CARE COMPOSITIONS | Dow Global Technologies LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| EP-4508054-A1 | PREPARATION OF ORGANOSILICON COMPOUNDS WITH VINYLESTER FUNCTIONALITY | Dow Global Technologies LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| WO-1997015542-A1 | PROCESS FOR PURIFYING A 2,6-DIALKYLPHENOL | ALBEMARLE CORPORATION (US) | 1997-05-01 | — | — | WO | disclosed |
| US-5591311-A | 2,6-DIISOPROPYLPHENOL | ALBEMARLE CORPORATION (US) | 1997-01-07 | — | — | US | disclosed |
| EP-0445827-B1 | 4-Hydroxytetrahydropyran-2-one derivatives useful as cholesterol and lipid reducing agents | FUJIREBIO KK (JP) | 1996-09-25 | — | — | EP | disclosed |
| US-5149834-A | Anticholesterol agent and enzyme inhibitors, for curing arteriosclerosis | FUJIREBIO INC. (JP) | 1992-09-22 | — | — | US | disclosed |
| US-5059598-A | Antiinflammatory agents; lipoxygenase inhibitors; arthritis; asthma | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1991-10-22 | — | — | US | disclosed |
| EP-0445827-A2 | 4-Hydroxytetrahydropyran-2-one derivatives useful as cholesterol and lipid reducing agents | FUJIREBIO INC. (JP) | 1991-09-11 | — | — | EP | disclosed |
| US-4868183-A | ANTIINFLAMMATORY, ENZYME INHIBITORS | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1989-09-19 | — | — | US | disclosed |
| EP-0254259-A2 | p-Aminophenol derivatives | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1988-01-27 | — | — | EP | disclosed |
| US-3944632-A | Phosphoric acid anilides | CIBA-GEIGY CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378264-B2 | Multifunctional organosilicon compound and related methods, compounds, and compositions | MSR1, OXSR1, RIOX2 | CDC25A 2029/4885CDC25B 925/4885PTPN1 3602/4885 |
| US-20250136763-A1 | SILICONE - VINYLESTER FUNCTIONAL COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN PERSONAL CARE COMPOSITIONS | VCL, FANCF, MMS19 | CDC25A 3910/4885CDC25B 4348/4885PTPN1 3434/4885 |
| US-12371535-B2 | Branched organosilicon compound, method of preparing same, and copolymer formed therewith | OXSR1, BRS3, OXER1 | CDC25A 3598/4885CDC25B 2532/4885PTPN1 1779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.